中文 | English
Return
Total: 1029 , 1/103
Show Home Prev Next End page: GO
Author:( Juan, MA)

1.Prevention of the adverse reaction application of bevacizumab in combination with chemotherapy in postoperative patients with gastric cancer

Yaoming HE ; Juan MA

Clinical Medicine of China 2016;32(5):400-403

2.Comparative prognosis efficacy between total laparoscopic gastrectomy and ordinary gastric cancer for familial gastric cancer

Xiaoan WANG ; Juan MA

Practical Oncology Journal 2015;(4):311-314

3.Research progress of metabolic syndrome in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Juan LIN ; Huamei MA

Chinese Journal of Applied Clinical Pediatrics 2016;31(8):631-634

4.Research progress in radiotherapy for head and neck tumors in parotid gland protection

Juan LIU ; Daiyuan MA

Journal of International Oncology 2015;42(9):689-692

5.Long-term survival and metabolic syndrome in childhood cancer

Juan LIN ; Huamei MA

International Journal of Pediatrics 2014;(5):496-499,500

6.A Survey on the Current Situation of Smoking and Smoking Cessation in 184 Patients with Cardiovascular Disease

Juan MA ; Jili CHEN

Journal of Kunming Medical University 2013;(12):60-64

7.Comparative analysis of outcome of radioiodine and antithyroid medication in treating Graves'disease in children and adolescents:a systematic evaluation

Xiao-Juan MA ; An-Ren KUANG ;

Chinese Journal of Endocrinology and Metabolism 2000;0(06):-

8. Moxonidine-induced transient pressor response is mediated by both I1-imidazoline receptors and α2-adrenoceptors in anesthetized spontaneously hypertensive rats

Xiu-Juan MA

Academic Journal of Second Military Medical University 2010;28(6):581-588

9.The clinical phenotype analysis of 116 congenital cataract patients in Yunnan province

Juan-juan, LI ; Xuan, MA ; Zhu-lin, HU

Chinese Journal of Experimental Ophthalmology 2011;29(11):1002-1004

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1029 , 1/103 Show Home Prev Next End page: GO